Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|July 15, 2022
Onco-nephrology: Physicians' Expectations About a New SubspecialtyMatthieu Delaye, Mélanie Try, Adrien Rousseau, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2020
Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitorsDenis Maillet, Pauline Corbaux, Jean-Jacques Stelmes, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 2024
Patients' knowledge about renal secondary effects of anti-tumoral drugs and renal protection measuresPauline Corbaux, Matthieu Bainaud, Adrien Rousseau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2024
Intraperitoneal Nivolumab after Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: A Phase I Study with Expansion CohortPauline Corbaux, Gilles Freyer, Olivier Glehen, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 7, 2025
Prognostic Value of a Joint K-PD Model With Tumor Size Dynamics and CA-125 Kinetics in Recurrent Ovarian Cancer Patients: BOLD Phase II GINECO StudyAurore Carrot, Pauline Corbaux, Olivier Colomban, et al.
Cancers|June 2, 2021
Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival OutcomesCharline Lafayolle de la Bruyère, Pierre-Jean Souquet, Stéphane Dalle, et al.
Cancers|January 11, 2022
The Increasing Prognostic and Predictive Roles of the Tumor Primary Chemosensitivity Assessed by CA-125 Elimination Rate Constant K (KELIM) in Ovarian Cancer: A Narrative ReviewAmbroise Lauby, Olivier Colomban, Pauline Corbaux, et al.
Head & Neck|May 1, 2026
Systemic Treatments for Recurrent or Metastatic Sinonasal Carcinomas: A Retrospective Multicenter StudyMarie Degrange, Mathilde Morisseau, Justin Michel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 9, 2026
Differences in first-line chemosensitivity assessed by ELIMination rate constant K in advanced serous ovarian cancer: evidence from Western and Japanese Trials in a Gynecologic Cancer InterGroup meta-analysisPauline Corbaux, Benoit You, Iain McNeish, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 19, 2025
Identifying high-risk relapse in early-stage I to II ovarian cancer using the CA125 ELIMination rate constant K (KELIM) score: a Gynecologic Cancer InterGroup individual patient-data meta-analysisPauline Corbaux, Benoit You, Tatsuo Kagimura, et al.
Pageof 3